Injectable iron-modified apatitic bone cement intended for kyphoplasty: cytocompatibility study

J Mater Sci Mater Med. 2008 Dec;19(12):3575-83. doi: 10.1007/s10856-008-3513-3. Epub 2008 Jul 15.

Abstract

In this study, the cytocompatibility of human ephitelial (HEp-2) cells cultured on new injectable iron-modified calcium phosphate cements (IM-CPCs) has been investigated in terms of cell adhesion, cell proliferation, and morphology. Quantitative MTT-assay and scanning electron microscopy (SEM) showed that cell adhesion and viability were not affected with culturing time by iron concentration in a dose-dependent manner. SEM-cell morphology showed that HEp-2 cells, seeded on IM-CPCs, were able to adhere, spread, and attain normal morphology. These results showed that the new injectable IM-CPCs have cytocompatible features of interest to the intended kyphophasty application, for the treatment of osteoporotic vertebral compression fractures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apatites / chemistry
  • Biocompatible Materials / administration & dosage*
  • Bone Cements*
  • Calcium Phosphates / administration & dosage
  • Carcinoma / pathology
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • Dose-Response Relationship, Drug
  • Epithelial Cells / ultrastructure
  • Formazans / analysis
  • Humans
  • Injections
  • Iron / chemistry
  • Iron / pharmacology
  • Laryngeal Neoplasms / pathology
  • Substrate Specificity
  • Tetrazolium Salts / analysis
  • Time Factors
  • Vertebroplasty / methods*

Substances

  • Apatites
  • Biocompatible Materials
  • Bone Cements
  • Calcium Phosphates
  • Formazans
  • Tetrazolium Salts
  • MTT formazan
  • calcium phosphate
  • Iron